Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

被引:94
作者
Pérez-Simón, JA
Díez-Campelo, M
Martino, R
Brunet, S
Urbano, A
Caballero, MD
León, A
Valcárcel, D
Carreras, E
del Cañizo, MC
López-Fidalgo, J
Sierra, J
San Miguel, JF
机构
[1] Hosp Clin Univ Salamanca, Hematol Serv, Salamanca 37007, Spain
[2] Hosp Santa Cruz & San Pablo, E-08025 Barcelona, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Gen Jerez Frontera, Jerez de la Frontera, Spain
[5] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain
关键词
graft-versus-host disease; conventional myeloablative regimen; reduced intensity conditioning; allogeneic transplantation; comparison;
D O I
10.1111/j.1365-2141.2005.05614.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The graft-versus-host disease (GVHD) characteristics of 150 consecutive patients undergoing reduced intensity conditioning allogeneic (allo-RIC) transplants and 88 patients undergoing myeloablative conditioning regimen were analysed. All patients received the same GVHD prophylaxis and peripheral blood stem cells from a human leucocyte antigen identical sibling. The cumulative incidence of acute GVHD (aGVHD) was 67% and 44% in the myeloablative and allo-RIC regimen groups, respectively (P < 0.001), and was 39% vs. 29%, respectively (P = 0.043), for grades 2-4 aGVHD. Only conditioning type (myeloablative versus allo-RIC) significantly influenced the incidence of aGVHD in multivariate analysis: Hazard ratio (HR) = 2.16 [95% confidence interval (CI): 1.52-3.07], P < 0.0001. The cumulative incidence of chronic GVHD (cGVHD) was 63% and 71% among myeloablative and allo-RIC patients respectively (P = 0.084). This trend was because of the higher incidence of limited cGVHD, but not extensive cGVHD among allo-RIC recipients [HR = 3.3 (95% CI: 1.42-8.08), P = 0.0017]. Moreover, among patients who developed cGVHD, the cumulative incidence of limited cGVHD was significantly lower in the myeloablative group than in the allo-RIC group (7% vs. 25%, P = 0.007). Duration of immunosuppression was shorter among allo-RIC patients (35.5% vs. 68.8% required systemic immunosuppression 36 months after transplant, P = 0.028). Although prospective controlled trials are required to further evaluate the effect of the conditioning regimen on GVHD, our results suggest that RIC modifies the incidence and characteristics of both acute and cGVHD after allogeneic transplantation, and decreases the immunosuppression requirements in long-term follow up when compared with myeloablative conditioning.
引用
收藏
页码:394 / 403
页数:10
相关论文
共 45 条
  • [1] Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study
    Akpek, G
    Lee, SJ
    Flowers, ME
    Pavletic, SZ
    Arora, M
    Lee, S
    Piantadosi, S
    Guthrie, KA
    Lynch, JC
    Takatu, A
    Horowitz, MM
    Antin, JH
    Weisdorf, DJ
    Martin, PJ
    Vogelsang, GB
    [J]. BLOOD, 2003, 102 (03) : 802 - 809
  • [2] Development of a prognostic model for grading chronic graft-versus-host disease
    Akpek, G
    Zahurak, ML
    Piantadosi, S
    Margolis, J
    Doherty, J
    Davidson, R
    Vogelsang, GB
    [J]. BLOOD, 2001, 97 (05) : 1219 - 1226
  • [3] BOLWELL BJ, 2003, BLOOD, V102
  • [4] Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia
    Clift, RA
    Buckner, CD
    Appelbaum, FR
    Sullivan, KM
    Storb, R
    Thomas, ED
    [J]. BLOOD, 1998, 92 (04) : 1455 - 1456
  • [5] Mechanism for cotolerance in nonlethally conditioned mixed chimeras: Negative selection of the V-beta T-cell receptor repertoire by both host and donor bone marrow-derived cells
    Colson, YL
    Lange, J
    Fowler, K
    Ildstad, ST
    [J]. BLOOD, 1996, 88 (12) : 4601 - 4610
  • [6] Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease
    Cooke, KR
    Hill, GR
    Crawford, JM
    Bungard, D
    Brinson, YS
    Delmonte, J
    Ferrara, JLM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10) : 1882 - 1891
  • [7] Acute and chronic Graft-versus-Host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
    Couriel, DR
    Saliba, RM
    Giralt, S
    Khouri, I
    Andersson, B
    de Lima, M
    Hosing, C
    Anderlini, P
    Donato, M
    Cleary, K
    Gajewski, J
    Neumann, J
    Ippoliti, C
    Rondon, G
    Cohen, A
    Champlin, R
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) : 178 - 185
  • [8] Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X
  • [9] Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
    Flowers, MED
    Parker, PM
    Johnston, LJ
    Matos, AVB
    Storer, B
    Bensinger, WI
    Storb, R
    Appelbaum, FR
    Forman, SJ
    Blume, KG
    Martin, PJ
    [J]. BLOOD, 2002, 100 (02) : 415 - 419
  • [10] Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase
    Fujiwara, H
    El Ouriaghli, F
    Grube, M
    Price, DA
    Rezvani, K
    Gostick, E
    Sconocchia, G
    Melenhorst, J
    Hensel, N
    Douek, DC
    Barrett, AJ
    [J]. BLOOD, 2004, 103 (08) : 3076 - 3083